People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study 

AI Summary

A real-world study found that patients switching from Novo Nordisk's obesity injections to its Wegovy pill continued to lose weight. The findings suggest some patients may be able to move from weekly injections to a more convenient oral treatment.

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.